Procurement Summary
Country : Italy
Summary : Convention with the Irccs Foundation National Institute of Cancer for the Execution of Dosages of the Soluble Receptor of the Transferrin in the Context of the Clinical Study Entitled: "Phase 1 Study, ....
Deadline : 27 Jun 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 120867460
Document Ref. No. :
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Convention with the IRCCS Foundation National Cancer Institute for the execution of dosages of the soluble receptor of the transferrin in the context of the clinical study entitled: "Phase 1 study, multicenter, not randomized in open, adaptive and a growing single dose aimed at examining the Safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of Ro7121932 after intravenous administration in patients with multiple sclerosis (BP42230)".
No act: 460
Act date: 11/06/2025
Publication period: from 12/06/2025 to 27/06/2025
Category: Resolution
Publication start date: 12/06/2025
End of publication date: 06/27/2025
Documents
Tender Notice